Drug donanemab seen as turning point in dementia fight
bbc.com
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
For anyone interested in neuroscience, https://kbin.social/m/neuro was just launched :)